Top compounds associated with response to KRT12

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	lenalidomide	GDSC1000	pan-cancer	AAC	0.04	0.3
mRNA	Sorafenib	GDSC1000	pan-cancer	AAC	0.06	0.3
mRNA	Crizotinib	gCSI	pan-cancer	AAC	-0.063	0.3
mRNA	Doxorubicin	gCSI	pan-cancer	AAC	-0.057	0.3
mRNA	SU11274	CTRPv2	pan-cancer	AAC	-0.04	0.3
mRNA	BRD-K71935468	CTRPv2	pan-cancer	AAC	-0.043	0.3
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.038	0.3
mRNA	BRD-K27188169:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.059	0.3
mRNA	CHEMBL1222381	CTRPv2	pan-cancer	AAC	0.037	0.3
mRNA	Elesclomol	GDSC1000	pan-cancer	AAC	0.038	0.3

Download CSV